Richard C. Malabre
Chief Accounting Officer
Akebia Therapeutics, Inc. (AKBA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard C. Malabre
Richard C. Malabre is recorded as Chief Accounting Officer at Akebia Therapeutics, Inc. (AKBA). Akebia Therapeutics, Inc. reported in an 8-K filed January 8, 2024 that Richard C. Malabre was appointed Chief Accounting Officer and principal accounting officer, effective January 8, 2024.
“On January 8, 2024, Akebia Therapeutics, Inc. (the "Company") announced the appointment of Richard C. Malabre as Chief Accounting Officer and principal accounting officer, effective January 8, 2024 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Akebia Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- John Butler CEO, CFO, Board Member
- John P. Butler CEO, Board Member
- Ellen Snow CFO
- Erik Ostrowski CFO
- Michel Dahan COO
- David A. Spellman Chief Accounting Officer
- Adrian Adams Board Member
- LeAnne M. Zumwalt Board Member
- Michael Rogers Board Member
- Myles Wolf, M.D., M.M.Sc. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.